Federated Hermes’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-156,284
| Closed | -$13.6M | – | 2071 |
|
|
2024
Q4 | $13.6M | Buy |
156,284
+2,983
| +2% | +$260K | 0.03% | 490 |
|
|
2024
Q3 | $14.2M | Buy |
153,301
+90,947
| +146% | +$8.41M | 0.03% | 497 |
|
|
2024
Q2 | $6.72M | Buy |
62,354
+13,579
| +28% | +$1.46M | 0.02% | 639 |
|
|
2024
Q1 | $4.63M | Buy |
48,775
+24,732
| +103% | +$2.35M | 0.01% | 745 |
|
|
2023
Q4 | $2.22M | Buy |
+24,043
| New | +$2.22M | 0.01% | 922 |
|
|
2022
Q1 | – | Sell |
-388
| Closed | -$42K | – | 2199 |
|
|
2021
Q4 | $42K | Sell |
388
-26
| -6% | -$2.81K | ﹤0.01% | 1809 |
|
|
2021
Q3 | $43K | Sell |
414
-43,843
| -99% | -$4.55M | ﹤0.01% | 1875 |
|
|
2021
Q2 | $3.89M | Sell |
44,257
-30,950
| -41% | -$2.72M | 0.01% | 898 |
|
|
2021
Q1 | $7.31M | Sell |
75,207
-41,267
| -35% | -$4.01M | 0.01% | 750 |
|
|
2020
Q4 | $13.1M | Buy |
116,474
+107,534
| +1,203% | +$12.1M | 0.03% | 570 |
|
|
2020
Q3 | $829K | Buy |
+8,940
| New | +$829K | ﹤0.01% | 1315 |
|
|
2019
Q4 | – | Sell |
-6
| Closed | -$1K | – | 2213 |
|
|
2019
Q3 | $1K | Sell |
6
-142,748
| -100% | -$23.8M | ﹤0.01% | 2077 |
|
|
2019
Q2 | $13.5M | Buy |
+142,754
| New | +$13.5M | 0.03% | 476 |
|
|
2018
Q2 | – | Sell |
-74,933
| Closed | -$6.87M | – | 2198 |
|
|
2018
Q1 | $6.87M | Buy |
+74,933
| New | +$6.87M | 0.02% | 531 |
|
|
2017
Q3 | – | Sell |
-32,487
| Closed | -$1.65M | – | 2139 |
|
|
2017
Q2 | $1.65M | Buy |
32,487
+8,607
| +36% | +$436K | ﹤0.01% | 1009 |
|
|
2017
Q1 | $955K | Hold |
23,880
| – | – | ﹤0.01% | 1178 |
|
|
2016
Q4 | $670K | Buy |
23,880
+4,618
| +24% | +$130K | ﹤0.01% | 1232 |
|
|
2016
Q3 | $572K | Buy |
+19,262
| New | +$572K | ﹤0.01% | 1247 |
|